CV
HEALTHCARECapsoVision Inc
$7.01-0.05 (-0.71%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving CV Today?
No stock-specific AI insight has been generated for CV yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$3.43$15.37
$7.01
Fundamentals
Market Cap$349M
P/E Ratio—
EPS$-1.03
Dividend Yield—
Dividend / Share—
ROE-1.8%
Profit Margin-1.9%
Debt / Equity—
Trading
Volume77K
Avg Volume (10D)—
Shares Outstanding49.8M
CV News
20 articles- CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026Yahoo Finance·Apr 30, 2026
- CapsoVision And 2 Other Growth Stocks With Significant Insider OwnershipYahoo Finance·Apr 24, 2026
- CapsoVision Q4 Earnings Call HighlightsMarketbeat·Mar 26, 2026
- CapsoVision Reports Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Mar 26, 2026
- CapsoVision Conference: CEO Maps AI-Driven Capsule Endoscopy Roadmap for Colon and Pancreas ScreeningMarketbeat·Mar 24, 2026
- CapsoVision Announces $14 Million Private Placement FinancingYahoo Finance·Mar 20, 2026
- CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026Yahoo Finance·Mar 12, 2026
- CapsoVision to Participate in the 38th Annual ROTH ConferenceYahoo Finance·Mar 9, 2026
- Is CapsoVision (NASDAQ:CV) In A Good Position To Deliver On Growth Plans?Yahoo Finance·Feb 16, 2026
- Insider-Owned Growth Stocks Poised For Success In January 2026Yahoo Finance·Jan 20, 2026
- CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam PlusYahoo Finance·Jan 2, 2026
- CapsoVision Announces 510(k) Submission for the Addition of AI-Assisted Reading Module in CapsoCam Plus®Yahoo Finance·Dec 29, 2025
- Insiders Favor These 3 Prominent Growth CompaniesYahoo Finance·Dec 12, 2025
- CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor ConferenceYahoo Finance·Nov 20, 2025
- CapsoVision Reports Third Quarter 2025 Financial ResultsYahoo Finance·Nov 13, 2025
- November 2025's High Growth Companies With Insider InfluenceYahoo Finance·Nov 13, 2025
- CapsoVision Submits Breakthrough Device Designation Application to FDA for Pancreatic Cancer Screening CapsuleYahoo Finance·Nov 10, 2025
- DraftKings, Flutter downgraded: Wall Street's top analyst callsYahoo Finance·Nov 4, 2025
- CapsoVision Appoints David Garcia as Senior Vice President of FinanceYahoo Finance·Nov 3, 2025
- CapsoVision to Release Third Quarter 2025 Financial Results on Thursday, November 13, 2025Yahoo Finance·Oct 30, 2025
All 20 articles loaded
Price Data
Open$7.14
Previous Close$7.06
Day High$7.15
Day Low$7.14
52 Week High$15.37
52 Week Low$3.43
52-Week Range
$3.43$15.37
$7.01
Fundamentals
Market Cap$349M
P/E Ratio—
EPS$-1.03
Dividend Yield—
Dividend / Share—
ROE-1.8%
Profit Margin-1.9%
Debt / Equity—
Trading
Volume77K
Avg Volume (10D)—
Shares Outstanding49.8M
About CapsoVision Inc
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company is headquartered in Saratoga, California.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—